A red headed step child doesn't mislead. Having 1 or 100 orphan indications are great but mean absolutely nothing if INDs aren't submitted for the FDA and get approved with Orphan status. SO until the company actually does so, this is just another glossy PR that has sizzle but when you look closely, their still is no steak.

I know there are a lot of level headed investors that are waiting for the hyperbole to actually materialize.